Powder, Tablet

Sanofi Aventis

Sabril (vigabatrin) is used for the adjunctive management of epilepsy which is not satisfactorily controlled by conventional therapy.

Do not take Sabril (vigabatrin) if you are allergic to any ingredient in Sabril (vigabatrin) or to similar medications.

Before using Sabril (vigabatrin), tell your health care provider about any of the following: if you are pregnant, plan on becoming pregnant, or breastfeeding if you are taking or planning to take any prescription or nonprescription medicine if you have any other medical condition if you have high blood pressure

Sabril (vigabatrin) can cause drowsiness and fatigue. Patients should be advised to refrain from activities requiring mental alertness or physical coordination until they are sure that vigabatrin does not affect them adversely.

Other: Headache, impaired concentration, increased saliva, insomnia, muscle weakness, nausea, speech disorder, thinking abnormally, vomiting, weight gain

How much medicine you take and how often you take it depend on many factors, including the condition being treated and the age and weight of the patient. If you have any questions about the amount and/or frequency of Sabril (vigabatrin) you are taking, talk with your health care provider. Do not stop taking Sabril (vigabatrin) without checking with your health care provider. Patients with previous medical conditions should talk with their health care provider before taking Sabril (vigabatrin). Do not take more medicine than prescribed unless advised to do so by your health care provider. Do not take any other over-the-counter or prescription medications without talking with your health care provider. If a dose is missed, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. If more than one dose is missed, contact your health care provider or pharmacist. A number of different types of eye problems have been reported for people taking Sabril (vigabatrin) often in combination with other anti-epileptic medications. The onset of problems has occurred from less than one month to over six years after start of treatment. The onset of symptoms tends to be reported most frequently within the first year of treatment. Eye examinations are recommended at the start of treatment with Sabril (vigabatrin) and should continue to take place every three months. Anyone taking Sabril (vigabatrin) should report narrowing of the field of vision or loss of visual sharpness to their doctors and should be advised to promptly report any emerging visual problems. The use of Sabril (vigabatrin) should be stopped if eye problems occur unless the benefit of controlling seizures through continued treatment outweighs the risk of visual impairment.

Store Sabril (vigabatrin) at room temperature in a cool dry place, protect from heat and light. Keep all medicines out of the reach of children and pets.